Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-11

Clinical Trial Update: The Effects of Liraglutide on Sudomotor Function and Inflammation in Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating the effects of liraglutide on sudomotor function and inflammation in type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)

Snippet

Sponsor: Eastern Virginia Medical School | Conditions: Autonomic Nervous System Diseases, Sweat Gland Diseases | Phase 2 | Status: UNKNOWN